These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 20727021

  • 1. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.
    Houghton O, Jamison J, Wilson R, Carson J, McCluggage WG.
    Histopathology; 2010 Sep; 57(3):342-50. PubMed ID: 20727021
    [Abstract] [Full Text] [Related]

  • 2. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
    Park KJ, Kiyokawa T, Soslow RA, Lamb CA, Oliva E, Zivanovic O, Juretzka MM, Pirog EC.
    Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
    [Abstract] [Full Text] [Related]

  • 3. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
    Carleton C, Hoang L, Sah S, Kiyokawa T, Karamurzin YS, Talia KL, Park KJ, McCluggage WG.
    Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
    Yasutake N, Yamamoto H, Kuga R, Jiromaru R, Hongo T, Katayama Y, Sonoda K, Yahata H, Kato K, Oda Y.
    Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
    [Abstract] [Full Text] [Related]

  • 5. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A, Vang R, Seidman JD, Gravitt PE, Ronnett BM.
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [Abstract] [Full Text] [Related]

  • 6. Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas.
    Milde-Langosch K, Riethdorf S, Kraus-Pöppinghaus A, Riethdorf L, Löning T.
    Virchows Arch; 2001 Jul; 439(1):55-61. PubMed ID: 11499840
    [Abstract] [Full Text] [Related]

  • 7. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG, Shah R, Connolly LE, McBride HA.
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [Abstract] [Full Text] [Related]

  • 8. Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study.
    Jenkins D, Molijn A, Kazem S, Pirog EC, Alemany L, de Sanjosé S, Dinjens W, Quint W.
    Int J Cancer; 2020 Nov 01; 147(9):2526-2536. PubMed ID: 32474915
    [Abstract] [Full Text] [Related]

  • 9. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
    Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA.
    Am J Surg Pathol; 2018 Feb 01; 42(2):214-226. PubMed ID: 29135516
    [Abstract] [Full Text] [Related]

  • 10. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.
    Kenny SL, McBride HA, Jamison J, McCluggage WG.
    Am J Surg Pathol; 2012 Jun 01; 36(6):799-807. PubMed ID: 22456609
    [Abstract] [Full Text] [Related]

  • 11. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.
    Ansari-Lari MA, Staebler A, Zaino RJ, Shah KV, Ronnett BM.
    Am J Surg Pathol; 2004 Feb 01; 28(2):160-7. PubMed ID: 15043304
    [Abstract] [Full Text] [Related]

  • 12. HPV infection and p16INK4A and TP53 expression in rare cancers of the uterine cervix.
    Missaoui N, Mestiri S, Bdioui A, Zahmoul T, Hamchi H, Mokni M, Hmissa S.
    Pathol Res Pract; 2018 Apr 01; 214(4):498-506. PubMed ID: 29572122
    [Abstract] [Full Text] [Related]

  • 13. Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype.
    Kusanagi Y, Kojima A, Mikami Y, Kiyokawa T, Sudo T, Yamaguchi S, Nishimura R.
    Am J Pathol; 2010 Nov 01; 177(5):2169-75. PubMed ID: 20829441
    [Abstract] [Full Text] [Related]

  • 14. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma.
    Missaoui N, Hmissa S, Frappart L, Trabelsi A, Ben Abdelkader A, Traore C, Mokni M, Yaacoubi MT, Korbi S.
    Virchows Arch; 2006 May 01; 448(5):597-603. PubMed ID: 16496173
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S, Barsan I, Hoang L, Patel P, Chiriboga L, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA.
    Am J Surg Pathol; 2018 Aug 01; 42(8):989-1000. PubMed ID: 29851704
    [Abstract] [Full Text] [Related]

  • 16. No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group.
    Wentzensen N, du Bois A, Kommoss S, Pfisterer J, von Knebel Doeberitz M, Schmidt D, Kommoss F.
    Int J Gynecol Pathol; 2008 Jan 01; 27(1):18-23. PubMed ID: 18156969
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical expression of cyclin D1, p16Ink4a, p21WAF1, and Ki-67 correlates with the severity of cervical neoplasia.
    Portari EA, Russomano FB, de Camargo MJ, Machado Gayer CR, da Rocha Guillobel HC, Santos-Rebouças CB, Brito Macedo JM.
    Int J Gynecol Pathol; 2013 Sep 01; 32(5):501-8. PubMed ID: 23896712
    [Abstract] [Full Text] [Related]

  • 18. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia.
    Riethdorf L, Riethdorf S, Lee KR, Cviko A, Löning T, Crum CP.
    Hum Pathol; 2002 Sep 01; 33(9):899-904. PubMed ID: 12378514
    [Abstract] [Full Text] [Related]

  • 19. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R, Gown AM, Farinola M, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Judson K, Ronnett BM.
    Am J Surg Pathol; 2007 May 01; 31(5):653-63. PubMed ID: 17460447
    [Abstract] [Full Text] [Related]

  • 20. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A, Ji H, Shih IeM, Wang TL, Wu LS, Ronnett BM.
    Am J Surg Pathol; 2009 Oct 01; 33(10):1504-14. PubMed ID: 19623034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.